Author: Alison Abritis

Caught Our Notice: A paper mistakenly ID’d a patient. Its retraction notice did, too. (Oops!)

What Caught Our Attention: Last year, a journal retracted a paper about a child who developed a rare complication related to the inherited disorder Gaucher Disease, after realizing it had inadvertently identified the child. It wasn’t an immediately obvious mistake — the authors listed the drugs the patient was taking, and in the case of one drug, there was only one child in the world taking it. For anyone in the know, that would make the child’s identity clear.

So retracting the paper makes sense — but publishing a retraction notice that spells out the issue in detail, including the name of the drug and the fact the patient was the only pediatric recipient, did not. So last month, the Journal of Pediatric Hematology/Oncology corrected the retraction notice, removing the name of the drug. (Phew.)

Continue reading Caught Our Notice: A paper mistakenly ID’d a patient. Its retraction notice did, too. (Oops!)

Caught Our Notice: A team from Harvard, Cornell, Cambridge, HHMI, and UCSF can’t reproduce a paper’s findings

What Caught Our Attention: Any time there’s an issue with a paper co-authored by researchers from such high-profile institutions as Harvard, Cornell, and the University of Cambridge, we take notice. In this case, the group — which included Laurie Glimcher, then-dean at Cornell, now president of the Dana-Farber Cancer Institute — chose to retract a 2013 paper from a Cell journal after learning they couldn’t reproduce some of the experiments. Continue reading Caught Our Notice: A team from Harvard, Cornell, Cambridge, HHMI, and UCSF can’t reproduce a paper’s findings

Caught Our Notice: Hey peer reviewers — did you even read this paper??

What Caught Our Attention: A tree of life paper has been axed — and based on the information in the retraction notice, we’re wondering how it ever passed peer review.

Specifically, the notice states a review of the paper found “concerns regarding the study design, methodology, and interpretation of the data.” Overall, the research “contradict(s) a large body of existing literature and do(es) not provide a sufficient level of evidence to support the claims made in the paper.” Um, so what did it get right?

Continue reading Caught Our Notice: Hey peer reviewers — did you even read this paper??

Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Title: Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction

What Caught Our Attention: PLOS ONE had a few reasons for retracting a 2015 paper about a treatment for kidney disease due to diabetes: For one, despite what the paper claims, the authors did not obtain ethical approval to conduct the reported animal experiments. In addition, the corresponding author had no idea the paper had been submitted and published. How could a corresponding author be kept in the dark? It turns out, the journal was given an incorrect email address for him, so he didn’t receive any communications around the paper. (One author apparently used a third party editing company.) Continue reading Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Caught Our Notice: Make love, not fake reviews — semen papers retracted

Titles: 

1) Study of enzyme activities and protein content of beluga (Huso huso) semen before and after cryopreservation

2) Determination of some blood and seminal plasma ions in the beluga, Huso huso (Linnaeus, 1758)

3) Effects of multiple collections on spermatozoa quality of Persian sturgeon, Acipenser persicus: Motility, density and seminal plasma composition

What Caught Our Attention: We won’t lie — any retractions of papers about fish semen (OK, any kind of semen) will make us stop and look. In this case, the journal retracted three papers submitted by the same researcher over concerns of fake review. In the end, the journal was concerned the papers were okayed by reviewers who weren’t “suitably qualified” to review the papers about the content and quality of semen from different fish species. (In fairness, we imagine the pool of qualified reviewers is relatively small.)

Continue reading Caught Our Notice: Make love, not fake reviews — semen papers retracted

Caught Our Notice: Researcher who once threatened to sue Retraction Watch now up to 19 retractions

Title: Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

What Caught Our Attention: We haven’t heard much about Bharat Aggarwal since his seven retractions in 2016 propelled him onto our leaderboard (and long after he threatened to sue Retraction Watch for our reporting). There was a whisper of a mention, when his name was listed as one of the organizers of a cancer conference from which MD Anderson (his former employer) had to publicly distance themselves as a co-sponsor. Continue reading Caught Our Notice: Researcher who once threatened to sue Retraction Watch now up to 19 retractions

Caught Our Notice: 54 problems in three scientific images equals one expression of concern

Title: Effects of microRNA-223 on morphine analgesic tolerance by targeting NLRP3 in a rat model of neuropathic pain

What Caught Our Attention: Usually, an Expression of Concern (EOC) offers general language about “concerns regarding the validity of the data” or “concerns regarding the integrity of the study.” Here the language is anything but, saying that 54 Western blot bands within three figures have problems such as “visible pasted joints,” “square border,” and numerous “appear to be the same band.”  According to the notice, the authors have not responded to requests for the original blots, so the editors are allowing the article to remain intact, choosing instead “to alert readers to these issues and allow them to arrive at their own conclusions regarding the figures.” Continue reading Caught Our Notice: 54 problems in three scientific images equals one expression of concern

Caught Our Notice: Researcher who sued PubPeer commenter up to 21 retractions

Titles: 1) Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells

2) Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents

What Caught Our Attention: Regular readers will be familiar with the saga involving Fazlul Sarkar and PubPeer: In 2014, Sarkar sued anonymous commenters on the site, claiming defamation (and that damaging comments may have cost him a new job). Although Sarkar won an initial ruling, it was overturned by an appeals court. In the midst of that, the ACLU (which represented PubPeer in the case) released a copy of a misconduct investigation report compiled by Sarkar’s institution, Wayne State University, which concluded that he had committed enough misconduct to warrant retracting 40 papers. The two latest notices, both of which cite Wayne State’s investigation, bring Sarkar’s total to 21.   Continue reading Caught Our Notice: Researcher who sued PubPeer commenter up to 21 retractions

Caught Our Notice: Gorilla paper in the mist? Journal flags ape hormone paper

Title: Biologically validating the measurement of oxytocin in western lowland gorilla (Gorilla gorilla gorilla) urine and saliva using a commercial enzyme immunoassay

What Caught Our Attention: Quite frankly, anything with “gorilla gorilla gorilla” in the title will catch our eye, even if it is just the scientific name of the western lowland gorilla. In this case, the journal issued an expression of concern over an “unintended discrepancy” that may have affected the paper, which validates the use of a tool to measure oxytocin in the apes’ urine and saliva. The authors voluntarily notified the editors of Primate of the potential issue, and the journal issued an Expression of Concern only one month after the article was published — which is pretty fast for a notice, although not a record (see this one, issued six days after publication).

We contacted the editor, who told us:

Continue reading Caught Our Notice: Gorilla paper in the mist? Journal flags ape hormone paper

Caught Our Notice: Duplicates, errors prompt two retractions for same author

Titles: 1) Angiopoietin-Like 4 Confers Resistance to Hypoxia/Serum Deprivation-Induced Apoptosis through PI3K/Akt and ERK1/2 Signaling Pathways in Mesenchymal Stem Cells

2) Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling Pathway

What Caught Our Attention: In the span of 48 hours, PLOS ONE retracted two papers this month that were co-authored by Bo Yu, based at Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment and The Second Affiliated Hospital of Harbin Medical University in China. Both notices cite multiple duplications and errors, and conclude:

Continue reading Caught Our Notice: Duplicates, errors prompt two retractions for same author